What the US Food and Drug Administration has cleared, approved and recalled on this topic, and the side effects people report.
Each number has its full source under its own list below.
1 new medicines approved (since 1 Jan 2023). Medicines with a new active ingredient that the FDA approved, whose label lists a use on this topic.
Approved for: WAYRILZ is indicated for the treatment of adult patients with persistent or chronic immune thrombocytopenia (ITP) who have had an insufficient response to a previous treatment. WA…
Source: openFDA, Novel drug approvals (new molecular entities and new biologics), since 1 Jan 2023. Retrieved 12 Nov 2026.
1 recalls (since 1 Jan 2023). Recalls of medicines for this topic, newest first.
Reason: Failed Stability Specifications: Out of specification stability result for the protein concentration profile.
Source: openFDA, Drug recall enforcement reports, since 1 Jan 2023. Retrieved 12 Nov 2026.
2 recalls (since 1 Jan 2023). Recalls of medical devices for this topic, newest first.
Reason: Vial-to-vial variability in MAS Omni"IMMUNE PRO Liquid Assayed Integrated Immunoassay Control, Level 1, Lot OPRO29061A results in low Parathyroid Hormone (PTH) recovery, which may lead to a delay in…
Reason: The firm has identified that the Transferrin reagent does not meet the Instructions for Use (IFU) reagent on-board stability claims, which may cause control failures and/or erroneous patient samples…
Source: openFDA, Medical device recalls, since 1 Jan 2023. Retrieved 12 Nov 2026.
15,052 side effect reports (reports received since 1 Jan 2023). The reactions named most often in reports about medicines used for this topic.
Anyone can send a report. A report does not prove that the medicine caused the reaction, and the counts do not show how often it happens.
Source: openFDA, FDA Adverse Event Reporting System (FAERS), reports by reaction, reports received since 1 Jan 2023. Retrieved 12 Nov 2026.
Worldwide · 2024–2034
View report PharmaceuticalsWorldwide · 2024–2034
View report OTC & NutraceuticalsWorldwide · 2024–2034
View report OTC & NutraceuticalsWorldwide · 2024–2034
View report OTC & NutraceuticalsWorldwide · 2024–2034
View report OTC & NutraceuticalsWorldwide · 2024–2034
View report
Seasonal flu causes about a billion cases a year. Vitamin C and zinc can shorten colds a little, but vaccines…
Read
Atopic dermatitis is the most common chronic skin condition, affecting about 225 million people, mostly…
ReadAcuitas market sizes and forecasts are only in our full reports. How we use public data.